Case number 2020-1076
Ferring B.V. v. Allergan, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 12, 2019 | 18 | ORDER granting Serenity's motion to dismiss [17]. Appeal No. 2020-1076 is dismissed. The revised official caption and short caption for the remaining appeal, Appeal No. 2020-1098, are reflected in this order. Each side shall bear its own costs in Appeal No. 2020-1076. Ferring B.V., Ferring International Center SA, and Ferring Pharmaceuticals, Inc.'s opening brief in Appeal No. 2020-1098 is due within 60 days of the date of filing of this order. ISSUED AS A MANDATE (as to 2020-1076 only): December 12, 2019. Service as of this date by the Clerk of Court. [655970] [20-1076, 20-1098] [LMS] [Entered: 12/12/2019 11:24 AM] (3) |
| Nov 22, 2019 | 17 | MOTION of Appellants Reprise Biopharmaceutics, LLC, Serenity Pharmaceuticals Corporation and Serenity Pharmaceuticals, LLC to terminate appeal through Dismissal. Cases to be terminated: 2020-1076. (Briefing suspended pursuant to FCR 31 pending resolution of the motion). [Consent: unopposed]. Service: 11/22/2019 by email. [651889] [20-1076]--[Edited 11/25/2019 by CAB to add correct relief] [Paul Skiermont] [Entered: 11/22/2019 08:05 PM] (6) |
| Nov 7, 2019 | 4 | Entry of appearance for Mary W. Bourke as principal counsel for Cross-Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647877] [20-1076] [Mary Bourke] [Entered: 11/07/2019 04:15 PM] (2) |
| Nov 7, 2019 | 5 | Entry of appearance for Dana K. Severance as of counsel for Cross-Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647880] [20-1076] [Dana Severance] [Entered: 11/07/2019 04:17 PM] (2) |
| Nov 7, 2019 | 6 | Entry of appearance for John W. Cox as of counsel for Cross-Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647882] [20-1076] [John Cox] [Entered: 11/07/2019 04:19 PM] (2) |
| Nov 7, 2019 | 7 | Entry of appearance for Joshua P. Davis as of counsel for Cross-Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647883] [20-1076] [Joshua Davis] [Entered: 11/07/2019 04:21 PM] (2) |
| Nov 7, 2019 | 8 | Entry of appearance for Kristen Healey Cramer as of counsel for Cross-Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647887] [20-1076] [Kristen Cramer] [Entered: 11/07/2019 04:22 PM] (2) |
| Nov 7, 2019 | 9 | Certificate of Interest for Cross-Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647899] [20-1076] [Mary Bourke] [Entered: 11/07/2019 04:30 PM] (3) |
| Nov 7, 2019 | 10 | Docketing Statement for the Cross-Appellants Ferring B.V., Ferring International Center SA and Ferring Pharmaceuticals Inc.. Service: 11/07/2019 by email. [647902] [20-1076] [Mary Bourke] [Entered: 11/07/2019 04:31 PM] (4) |
| Nov 7, 2019 | 11 | Entry of appearance for Joseph Evall as principal counsel for Appellees Allergan, Inc., Allergan USA, Inc. and Allergan Sales, LLC. Service: 11/07/2019 by email. [647956] [20-1076] [Joseph Evall] [Entered: 11/07/2019 08:02 PM] (2) |
| Nov 7, 2019 | 12 | Certificate of Interest for Appellees Allergan Sales, LLC, Allergan USA, Inc. and Allergan, Inc.. Service: 11/07/2019 by email. [647957] [20-1076] [Joseph Evall] [Entered: 11/07/2019 08:12 PM] (3) |
| Nov 7, 2019 | 13 | Docketing Statement for the Appellees Allergan Sales, LLC, Allergan USA, Inc. and Allergan, Inc.. Service: 11/07/2019 by email. [647958] [20-1076] [Joseph Evall] [Entered: 11/07/2019 08:30 PM] (3) |
| Nov 7, 2019 | 14 | Entry of appearance for Paul J. Skiermont as principal counsel for Appellants Serenity Pharmaceuticals Corporation, Serenity Pharmaceuticals, LLC and Reprise Biopharmaceutics, LLC. Service: 11/07/2019 by email. [647964] [20-1076] [Paul Skiermont] [Entered: 11/07/2019 11:29 PM] (2) |
| Nov 7, 2019 | 15 | Certificate of Interest for Appellants Serenity Pharmaceuticals Corporation, Serenity Pharmaceuticals, LLC and Reprise Biopharmaceutics, LLC. Service: 11/07/2019 by email. [647966] [20-1076] [Paul Skiermont] [Entered: 11/07/2019 11:31 PM] (3) |
| Nov 7, 2019 | 16 | Docketing Statement for the Appellants Serenity Pharmaceuticals Corporation, Serenity Pharmaceuticals, LLC and Reprise Biopharmaceutics, LLC. Service: 11/07/2019 by email. [647967] [20-1076] [Paul Skiermont] [Entered: 11/07/2019 11:33 PM] (3) |
| Nov 1, 2019 | 2 | ORDER filed. Appeals 20-1076 and 20-1098 are hereby consolidated. The briefing schedule is set forth in the order. The revised official caption is reflected in the order. Service as of this date by the Clerk of Court. [646490] [20-1076, 20-1098] [MMA] [Entered: 11/01/2019 04:47 PM] (2) |
| Nov 1, 2019 | 3 | Note to file: The following cases are associated: 20-1076 (Lead) with 20-1098 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [646492] [20-1076, 20-1098] [MMA] [Entered: 11/01/2019 04:51 PM] (0) |
| Oct 24, 2019 | 1 | Appeal docketed. Received: 10/23/2019. [644372]Entry of Appearance due 11/07/2019. Certificate of Interest is due on 11/07/2019. Docketing Statement due 11/07/2019. Appellants' brief is due 12/23/2019. [MMA] [Entered: 10/24/2019 10:45 AM] (45) |
